Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsHeather Dawn Agnew, Bert Tsunyin Lai, Anders Eliasen
Life of this patent
Estimating the term…
Abstract
The present application provides stable heterobiligands made up of peptide-based IDO1 ligands and small molecule inhibitors of IDO1 and methods of use of the heterobiligands as detection, imaging, diagnostic, and therapeutic agents. The application further provides methods of manufacturing IDO1 heterobiligands, capture agents, and imaging agents.
Claims17
A heterobiligand comprising a first ligand having affinity for an epitope on indoleamine 2,3-dioxygenase 1 (IDO1), a linker, and a second ligand, wherein the second ligand comprises a small molecule inhibitor of IDO1, wherein the linker links the first ligand and the second ligand, wherein the heterobiligand specifically binds and inhibits IDO1, wherein IDO1 comprises an active site, and wherein the small molecule inhibitor of IDO1 binds the IDO1 active site, wherein the first ligand comprises an amino acid sequence selected from the group consisting of wyvay (SEQ ID NO:2), wyaay (SEQ ID NO:
- 8), (F-Phe)n(Me-Trp)(Me-Trp)w (SEQ ID NO:5), (F-Phe)rhl(Me-Trp) (SEQ ID NO:
- 9), (F-Phe)t(Me-Trp)y(Me-Trp) (SEQ ID NO:10), G(F-Phe)nwk (SEQ ID NO:11), (Me-Trp)ffkf (SEQ ID NO:12), ndn(Me-Trp)w (SEQ ID NO:13), npv(F-Phe)w (SEQ ID NO:
- 14), ntk(Me-Trp)p (SEQ ID NO:15), n(Me-Trp)p(Me-Trp)f (SEQ ID NO:16), pp(Me-Trp)s(Me-Trp) (SEQ ID NO:17), yyy(Me-Trp)t (SEQ ID NO:18), and yfn(Me-Trp)(Me-Trp) (SEQ ID NO:19);
- and
- wherein the small molecule inhibitor of IDO1 is
- wherein X is S, O, or NH, wherein R1 is —CH2—R2—, —(CH2)n—R2—, absent, —(CH2—CH2—O)m—CH2—CH2—R2—, or —CH2—CH2—NH—SO2—R2—, wherein R2 is —CO— or —NH—, wherein n is an integer from 2 to 10, wherein m is an integer from 1 to 6.
Dependencies are inferred from the claim text.